In regard to this consultation, of the proposed options the CHF supports option 1A: to “publish names of excipient ingredients except those used in flavour or fragrance proprietary ingredient mixes”
We believe that given the serious risks associated with allergies and the increasingly wide range of ingredients that can cause allergic reactions, consumers should be able to know with certainty the entirety of the ingredients that are within medicines they intend to take.

Click on the link below to read our submission.